TELCON RF PHARMACEUTICAL. INC. financial statements, including revenue, expenses, and profit
The total revenue of 200230 for the last quarter is 13.84 B KRW, and it's 93.21% higher compared to the previous quarter. The net income of Q4 24 is -12.20 B KRW.